Skip to content
lifestyle.humane.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Amneal Pharmaceuticals LLC
Amneal Named BioSpace 2027 Best Place to Work, Ranking No.1 Among Large Employers
November 10, 2026
Amneal Reports Third Quarter 2026 Financial Results
November 3, 2026
Amneal to Report Third Quarter 2026 Results on November 3, 2026
October 8, 2026
Amneal Announces FDA Approval and Launch of Lanreotide Injection
September 18, 2026
Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader
August 10, 2026
Amneal Reports Second Quarter 2026 Financial Results
July 30, 2026
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
July 17, 2026
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
July 17, 2026
Amneal to Report Second Quarter 2026 Results on July 30, 2026
July 9, 2026
Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations
June 29, 2026
1
2
Next Page
→